The T/E1A-binding domain of the retinoblastoma product can interact selectively with a sequence-specific DNA-binding protein

[1]  A. Siddiqui,et al.  HBV X protein alters the DNA binding specificity of CREB and ATF-2 by protein-protein interactions , 1991, Science.

[2]  N. Copeland,et al.  Evi-1, a murine zinc finger proto-oncogene, encodes a sequence-specific DNA-binding protein , 1991, Molecular and cellular biology.

[3]  M. Sporn,et al.  Regulation of transforming growth factor beta 1 gene expression by the product of the retinoblastoma-susceptibility gene. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[4]  E. Y. Lee,et al.  A cellular protein that competes with SV40 T antigen for binding to the retinoblastoma gene product , 1991, Nature.

[5]  F. Kaye,et al.  Identification of cellular proteins that can interact specifically with the T/ElA-binding region of the retinoblastoma gene product , 1991, Cell.

[6]  H. Weintraub,et al.  Sequence-specific DNA binding by the c-Myc protein. , 1990, Science.

[7]  H. Weintraub,et al.  Differences and similarities in DNA-binding preferences of MyoD and E2A protein complexes revealed by binding site selection. , 1990, Science.

[8]  J. Nevins,et al.  Adenovirus E1A proteins can dissociate heteromeric complexes involving the E2F transcription factor: A novel mechanism for E1A trans-activation , 1990, Cell.

[9]  P. Robbins,et al.  Negative regulation of human c-fos expression by thes retinoblastoma gene product , 1990, Nature.

[10]  V. Garsky,et al.  Identification of HPV-16 E7 peptides that are potent antagonists of E7 binding to the retinoblastoma suppressor protein. , 1990, The Journal of biological chemistry.

[11]  L. Gold,et al.  Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. , 1990, Science.

[12]  J. Nevins,et al.  A role for the adenovirus inducible E2F transcription factor in a proliferation dependent signal transduction pathway. , 1990, The EMBO journal.

[13]  M. Ewen,et al.  Definition of the minimal simian virus 40 large T antigen- and adenovirus E1A-binding domain in the retinoblastoma gene product , 1990, Molecular and cellular biology.

[14]  P. Yaciuk,et al.  TGF-β1 inhibition of c-myc transcription and growth in keratinocytes is abrogated by viral transforming proteins with pRB binding domains , 1990, Cell.

[15]  W. Lee,et al.  Two distinct and frequently mutated regions of retinoblastoma protein are required for binding to SV40 T antigen. , 1990, The EMBO journal.

[16]  N. Dyson,et al.  The regions of the retinoblastoma protein needed for binding to adenovirus E1A or SV40 large T antigen are common sites for mutations. , 1990, The EMBO journal.

[17]  R. Weinberg,et al.  Frequent inactivation of the retinoblastoma anti-oncogene is restricted to a subset of human tumor cells. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[18]  S. Friend,et al.  Large T antigens of many polyomaviruses are able to form complexes with the retinoblastoma protein , 1990, Journal of virology.

[19]  W. Lee,et al.  Suppression of tumorigenicity of human prostate carcinoma cells by replacing a mutated RB gene. , 1990, Science.

[20]  K. Kinzler,et al.  The GLI gene encodes a nuclear protein which binds specific sequences in the human genome , 1990, Molecular and cellular biology.

[21]  David M. Livingston,et al.  The product of the retinoblastoma susceptibility gene has properties of a cell cycle regulatory element , 1989, Cell.

[22]  E. Harlow,et al.  The retinoblastoma protein is phosphorylated during specific phases of the cell cycle , 1989, Cell.

[23]  N. Dyson,et al.  The cellular 107K protein that binds to adenovirus E1A also associates with the large T antigens of SV40 and JC virus , 1989, Cell.

[24]  M. Ewen,et al.  An N-Terminal transformation-governing sequence of SV40 large T antigen contributes to the binding of both p110 Rb and a second cellular protein, p120 , 1989, Cell.

[25]  K. Kinzler,et al.  Whole genome PCR: application to the identification of sequences bound by gene regulatory proteins. , 1989, Nucleic acids research.

[26]  M Lipp,et al.  E1A-dependent trans-activation of the human MYC promoter is mediated by the E2F factor. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[27]  R. Weinberg,et al.  Point mutational inactivation of the retinoblastoma antioncogene. , 1989, Science.

[28]  E. Harlow,et al.  Cellular targets for transformation by the adenovirus E1A proteins , 1989, Cell.

[29]  P. L. Chen,et al.  Suppression of the neoplastic phenotype by replacement of the RB gene in human cancer cells. , 1988, Science.

[30]  D. Smith,et al.  Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase. , 1988, Gene.

[31]  Wen-Hwa Lee,et al.  SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene , 1988, Cell.

[32]  Wen-Hwa Lee,et al.  The retinoblastoma susceptibility gene encodes a nuclear phosphoprotein associated with DNA binding activity , 1987, Nature.

[33]  J. Nevins,et al.  Promoter interaction of the E1A‐inducible factor E2F and its potential role in the formation of a multi‐component complex. , 1987, The EMBO journal.

[34]  J. Nevins,et al.  Role of an adenovirus E2 promoter binding factor in E1A-mediated coordinate gene control. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[35]  Stephen H. Friend,et al.  A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma , 1986, Nature.

[36]  J. Nevins,et al.  Identification of a cellular transcription factor involved in E1A trans-activation , 1986, Cell.

[37]  W. Lee,et al.  Deletion of a splice donor site ablates expression of the following exon and produces an unphosphorylated RB protein unable to bind SV40 T antigen. , 1990, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[38]  W. Lee,et al.  C-terminal truncation of the retinoblastoma gene product leads to functional inactivation. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[39]  S. McKnight,et al.  Eukaryotic transcriptional regulatory proteins. , 1989, Annual review of biochemistry.

[40]  Robert Tjian,et al.  Promoter-specific activation of RNA polymerase II transcription by Sp1 , 1986 .